Cardio Diagnostics Holdings is trading at $2.16, up 6.4%, after opening under pressure amid dilution concerns ahead of its September 18, 2026 annual meeting.
- Shareholders are voting on authorization for up to 5.0 million shares or convertible securities, potentially raising $10.0 million at discounts of up to 25%.
- The stock was reported at $1.90, down 6.40% premarket from the September 17 close, before reversing higher during regular trading.